Universal Health Services, Inc. (UHS)
Healthcare · Medical - Care Facilities · Data as of 2026-09-01
Bottom line
UHS is trading at a discount to its history, in the middle of its recent price range, and recent volume shows no clear direction. The picture is mixed, so it may be worth watching rather than acting on. Past patterns are not a guarantee of future results.
Valuation — Trading at a discount to its history (Green)
UHS trades at 7.0× earnings, below its own 5-year average of 12× and below similar healthcare companies we track (29×, 52 peers). Historically this has been on the cheaper side for the stock. It also generates strong cash: a free-cash-flow yield of about 8%. Its current multiple sits around the 6th percentile of its own last five years — toward the low end of its own range. About 55% of its reported earnings arrived as free cash over the last year. Its fundamentals scored 7 of 9 on a standard year-over-year quality checklist — most of the underlying trends improved last fiscal year.
Price zones — In the middle of its recent range (Yellow)
At $170.75, the stock sits between its recent support and resistance levels. Over the past year UHS has traded between $140.08 and $246.33; its historical support zone sits near $161.88 and resistance near $186.89. It is above one of its moving averages and below the other — a mixed trend picture.
52-week range $140.08–$246.33 · 50-day average $161.88 · 200-day average $186.89
Money flow — No clear direction (Yellow)
Buying and selling volume in UHS have been fairly balanced recently, with no strong accumulation or distribution pattern. Volume on up days has been about 1.6× volume on down days over the last 30 sessions.
About the company
Universal Health Services, Inc. (UHS), operating through its various divisions, is a healthcare entity that both owns and manages a network of acute care hospitals, along with outpatient and specialized behavioral health treatment centers. Its business operations are strategically bifurcated into two main segments: Acute Care Hospital Services and Behavioral Health Care Services.
一句话结论
UHS 相对自身历史处于折价水平，处于近期价格区间的中部，近期成交量没有明确方向。整体情况好坏参半，也许更适合先观察，而不是急于行动。过去的形态并不能保证未来的结果。
估值 — 相对自身历史处于折价水平
UHS 目前的市盈率为 7.0×，低于其自身 5 年平均的 12×，并且低于我们追踪的同类Healthcare公司（29×，52 家）。从历史来看，这属于该股较便宜的一侧。它同时产生充沛的现金：自由现金流收益率约为 8%。它当前的估值倍数大约位于自身过去五年分布的第 6 百分位——处于自身区间的偏低位置。过去一年，其报告利润中约有 55% 转化为自由现金。在一套标准的逐年基本面核对清单上，它 9 项中通过了 7 项——上一财年多数底层趋势在改善。
价格区间 — 处于近期区间的中部
目前价格为 $170.75，位于其近期的支撑位与阻力位之间。过去一年 UHS 的价格在 $140.08 到 $246.33 之间波动；其历史支撑区在 $161.88 附近，阻力区在 $186.89 附近。它位于其中一条均线上方、另一条下方——趋势信号并不一致。
资金流向 — 方向不明确
UHS 近期的买卖成交量大致均衡，没有明显的吸筹或派发形态。过去 30 个交易日，上涨日的成交量约为下跌日的 1.6×。
UnderTheLight 用直白的语言解释股票——估值、价格区间与资金流向。它只描述数据，不构成任何投资建议。
UnderTheLight explains stocks in plain English — valuation, price zones and money flow as traffic lights, recomputed nightly. It describes data; it is not investment advice and never recommends a trade.